Sex hormones determine the risk of liver damage in children with overweight

Thema:
Efficient drug development
28 July 2026

Not every child with overweight develops liver damage, and sex hormones appear to play an important role. This is the finding of a study of 290 children by Maastricht UMC+ and TNO, to which LUMC and Amsterdam UMC also contributed. Oestradiol is associated with a healthier liver, whereas androgens such as testosterone are associated with more liver damage and fat accumulation, independently of BMI. The findings were recently published in Frontiers in Endocrinology.

Interestingly, oestradiol proved protective in both girls and boys, while testosterone was associated with an increased risk in both. Contrary to popular belief, both hormones are produced by boys and girls alike.

Oestradiol protective, testosterone harmful

In all 290 children, who are being treated at the Centre for Overweight Adolescent and Children's Healthcare (COACH) at Maastricht UMC+, liver values were measured and liver fat was assessed by ultrasound. Oestradiol, anti-Müllerian hormone (AMH) and sex hormone-binding globulin (SHBG) were associated with a healthier liver. Free and bioavailable testosterone and DHEAS, on the other hand, were associated with higher liver values and more fat accumulation in the children's livers.

Sex differences: a recurring theme in health research

The published study is one of several examples showing that sex differences are relevant to health risks, even at a young age, while research and diagnostics are still often designed around a single, sex-neutral norm. TNO is developing these insights further within its Metabolic Health and Women's Health research programmes, together with clinical partners such as Maastricht UMC+ and the MenoPause Consortium, to narrow the so-called health gap in healthcare.

More information

Read the full scientific article: Estradiol negatively associates with metabolic dysfunction-associated steatotic liver disease in children, published in Frontiers in Endocrinology.

This study is part of a broader TNO movement to better understand sex differences in health and to close the health gap. It arose partly from the collaboration between TNO's Efficient Drug Development (EDD) and Youth Health (YH) propositions. Would you like to work with TNO on this?

Explore, together with Anita van den Hoek, Symone Detmar, Robert Kleemann, Nicole van Kesteren and Arianne van Koppen, how our Women's Health and Child Health initiatives can contribute to research into sex-specific health risks, such as liver disease in children.

Get inspired

26 resultaten, getoond 1 t/m 5

Brain health

Informatietype:
Article
Discover how TNO studies brain health and the interaction between metabolism, vascular function, inflammation and ageing using advanced technologies and in vivo models.

Sarcopenia and frailty

Informatietype:
Article

RNA editing makes a protective gene variant available to patients who lack it naturally

Informatietype:
Insight
20 October 2026

14C-Pulse-Chase Technology

Informatietype:
Article

Obesity

Informatietype:
Article